circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer
© 2022 Wiley Periodicals LLC..
Small cell lung cancer (SCLC) is treated as a homogeneous disease, although the expression of NEUROD1, ASCL1, POU2F3, and YAP1 identifies distinct molecular subtypes. The MYC oncogene, amplified in SCLC, was recently shown to act as a lineage-specific factor to associate subtypes with histological classes. Indeed, MYC-driven SCLCs show a distinct metabolic profile and drug sensitivity. To disentangle their molecular features, we focused on the co-amplified PVT1, frequently overexpressed and originating circular (circRNA) and chimeric RNAs. We analyzed hsa_circ_0001821 (circPVT1) and PVT1/AKT3 (chimPVT1) as examples of such transcripts, respectively, to unveil their tumorigenic contribution to SCLC. In detail, circPVT1 activated a pro-proliferative and anti-apoptotic program when over-expressed in lung cells, and knockdown of chimPVT1 induced a decrease in cell growth and an increase of apoptosis in SCLC in vitro. Moreover, the investigated PVT1 transcripts underlined a functional connection between MYC and YAP1/POU2F3, suggesting that they contribute to the transcriptional landscape associated with MYC amplification. In conclusion, we have uncovered a functional role of circular and chimeric PVT1 transcripts in SCLC; these entities may prove useful as novel biomarkers in MYC-amplified tumors.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Genes, chromosomes & cancer - 62(2023), 7 vom: 16. Juli, Seite 377-391 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
AKT3 protein, human |
|---|
| Anmerkungen: |
Date Completed 10.05.2023 Date Revised 12.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/gcc.23121 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350736006 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350736006 | ||
| 003 | DE-627 | ||
| 005 | 20231226045652.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/gcc.23121 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1169.xml |
| 035 | |a (DE-627)NLM350736006 | ||
| 035 | |a (NLM)36562080 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tolomeo, Doron |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.05.2023 | ||
| 500 | |a Date Revised 12.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Wiley Periodicals LLC. | ||
| 520 | |a Small cell lung cancer (SCLC) is treated as a homogeneous disease, although the expression of NEUROD1, ASCL1, POU2F3, and YAP1 identifies distinct molecular subtypes. The MYC oncogene, amplified in SCLC, was recently shown to act as a lineage-specific factor to associate subtypes with histological classes. Indeed, MYC-driven SCLCs show a distinct metabolic profile and drug sensitivity. To disentangle their molecular features, we focused on the co-amplified PVT1, frequently overexpressed and originating circular (circRNA) and chimeric RNAs. We analyzed hsa_circ_0001821 (circPVT1) and PVT1/AKT3 (chimPVT1) as examples of such transcripts, respectively, to unveil their tumorigenic contribution to SCLC. In detail, circPVT1 activated a pro-proliferative and anti-apoptotic program when over-expressed in lung cells, and knockdown of chimPVT1 induced a decrease in cell growth and an increase of apoptosis in SCLC in vitro. Moreover, the investigated PVT1 transcripts underlined a functional connection between MYC and YAP1/POU2F3, suggesting that they contribute to the transcriptional landscape associated with MYC amplification. In conclusion, we have uncovered a functional role of circular and chimeric PVT1 transcripts in SCLC; these entities may prove useful as novel biomarkers in MYC-amplified tumors | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a MYC | |
| 650 | 4 | |a PVT1 | |
| 650 | 4 | |a circular RNA | |
| 650 | 4 | |a fusion transcript | |
| 650 | 4 | |a small cell lung cancer | |
| 650 | 7 | |a AKT3 protein, human |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins c-akt |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 700 | 1 | |a Traversa, Debora |e verfasserin |4 aut | |
| 700 | 1 | |a Venuto, Santina |e verfasserin |4 aut | |
| 700 | 1 | |a Ebbesen, Karoline K |e verfasserin |4 aut | |
| 700 | 1 | |a García Rodríguez, Juan L |e verfasserin |4 aut | |
| 700 | 1 | |a Tamma, Grazia |e verfasserin |4 aut | |
| 700 | 1 | |a Ranieri, Marianna |e verfasserin |4 aut | |
| 700 | 1 | |a Simonetti, Giorgia |e verfasserin |4 aut | |
| 700 | 1 | |a Ghetti, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Paganelli, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Visci, Grazia |e verfasserin |4 aut | |
| 700 | 1 | |a Liso, Arcangelo |e verfasserin |4 aut | |
| 700 | 1 | |a Kok, Klaas |e verfasserin |4 aut | |
| 700 | 1 | |a Muscarella, Lucia Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Fabrizio, Federico Pio |e verfasserin |4 aut | |
| 700 | 1 | |a Frassanito, Maria Antonia |e verfasserin |4 aut | |
| 700 | 1 | |a Lamanuzzi, Aurelia |e verfasserin |4 aut | |
| 700 | 1 | |a Saltarella, Ilaria |e verfasserin |4 aut | |
| 700 | 1 | |a Solimando, Antonio Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Fatica, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Ianniello, Zaira |e verfasserin |4 aut | |
| 700 | 1 | |a Marsano, René Massimiliano |e verfasserin |4 aut | |
| 700 | 1 | |a Palazzo, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Azzariti, Amalia |e verfasserin |4 aut | |
| 700 | 1 | |a Longo, Vito |e verfasserin |4 aut | |
| 700 | 1 | |a Tommasi, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Galetta, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Catino, Annamaria |e verfasserin |4 aut | |
| 700 | 1 | |a Zito, Alfredo |e verfasserin |4 aut | |
| 700 | 1 | |a Mazza, Tommaso |e verfasserin |4 aut | |
| 700 | 1 | |a Napoli, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Martinelli, Giovanni |e verfasserin |4 aut | |
| 700 | 1 | |a Kjems, Jørgen |e verfasserin |4 aut | |
| 700 | 1 | |a Kristensen, Lasse Sommer |e verfasserin |4 aut | |
| 700 | 1 | |a Vacca, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Storlazzi, Clelia Tiziana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Genes, chromosomes & cancer |d 1996 |g 62(2023), 7 vom: 16. Juli, Seite 377-391 |w (DE-627)NLM012637718 |x 1098-2264 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2023 |g number:7 |g day:16 |g month:07 |g pages:377-391 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/gcc.23121 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2023 |e 7 |b 16 |c 07 |h 377-391 | ||